ReviewCancers2022

Anti-Androgenic Therapies Targeting the Luminal Androgen Receptor of a Typical Triple-Negative Breast Cancer.

Avinash Khadela et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.